Sue Bloom - Physical Therapist

As a physical therapist, Sue Bloom has helped a diverse group of CARTICEL patients return to their active lifestyles.

Sue has spent her entire career in physical therapy. Recently, we asked her for her thoughts on what CARTICEL patients should expect from this big step in their recovery.


Q:     How long have you been a physical therapist?

A:     Over twenty years.

Q:     How long have you been working with CARTICEL patients?

A:     My first CARTICEL patient was approximately fifteen years ago.

Q:     How many CARTICEL patients do you see each year?

A:     Four or five. 

Q:     How do CARTICEL patients differ from your other patients?

A:     They're pretty much all very active and want to get back to a high level of function. Most CARTICEL patients are incredibly motivated.

Q:     What are your CARTICEL patients' attitudes like when they first start working with you?

A:     I think most of them are excited about the procedure. The real challenge is that many patients feel better six months post-op, so they’re convinced they can do anything, but patients really need to follow the rehab procedures to ensure proper healing. 

Q:     How long do you work with patients in your office?

A:     I would say anywhere from three to eight months. It really depends on the patient, the extent of their procedure and the type of insurance coverage.

Q:     On average, how many times a week do you see your CARTICEL patients?

A:     Initially, patients come in three times a week. After the first eight weeks, we'll usually see them twice a week and then at around five or six months about once a week. 

Q:     What would you say to patients who are considering CARTICEL but may be concerned about the time required for rehabilitation?

A:     If you can put the time in and really make an effort to follow the rehab guidelines, it is a great approach that you should definitely consider.

Q:     At what point do you enter the CARTICEL process?

A:     Usually I'll see people anywhere from two to four weeks after their procedure.

Q:     How do you and the surgeon work together?

A:     Communication with the surgeon is very important, because as the physical therapist, you need to know exactly how large and where the injury was. This information guides us on how aggressively or conservatively we approach therapy. There is also a lot of communication back and forth during follow-up appointments to ensure that the recovery is proceeding correctly.

Q:     What does the CARTICEL rehabilitation involve? 

A:     It varies a lot depending on the size and location of the repair and what other procedures you may have had. But typically, it involves stretching and range of motion work followed by trunk-strengthening, hip-strengthening and calf-strengthening exercises.

Q:     Are there goals or milestones that you set for your patients?

A:     From day one, we educate patients on the steps they need to take to return to an active lifestyle. Naturally, every case is different and it also depends on their doctors’ recommendations. In general, the goal is to achieve full range of motion within 12 weeks. It typical takes about 3 months to be able to completely bear weight without crutches. For patients with desk jobs, they may be able to return to work in just 2 to 3 weeks. If someone’s job requires a lot of walking, standing or lifting, it will take longer. Driving depends on what leg receives treatment. If it’s the left leg, most are driving again in 2 to 3 weeks—the right leg can take up to 8 weeks. Around 18 months, most people can safely return to the physical activities they enjoyed before their injury, including all types of sports.

Q:     What would you say to people who are concerned about pain?

A:     I don't think it should be a deciding factor to somebody, because compared to an improvement that could last a lifetime, the discomfort generally lasts a very short time.

Q:     In your opinion, what's the key to a successful outcome for CARTICEL rehabilitation?

A:     The most important thing is to be motivated and follow the rehabilitation guidelines. 

Was this content useful to you?:

Ready to get back to action with CARTICEL? You’re already on the right path.

I'm Ready

Indications and Usage

Carticel® (autologous cultured chondrocytes) is an autologous cellular product indicated for the repair of symptomatic cartilage defects of the femoral condyle (medial, lateral or trochlea), caused by acute or repetitive trauma, in patients who have had an inadequate response to a prior arthroscopic or other surgical repair procedure (e.g., debridement, microfracture, drilling/abrasion arthroplasty, or osteochondral allograft/autograft).

CARTICEL should only be used in conjunction with debridement, placement of a periosteal flap and rehabilitation. The independent contributions of the autologous cultured chondrocytes and other components of the therapy to outcome are unknown.

CARTICEL is not indicated for the treatment of cartilage damage associated with generalized osteoarthritis.

CARTICEL is not recommended for patients with total meniscectomy unless surgically reconstructed prior to or concurrent with CARTICEL implantation.

Important Safety Information

CARTICEL should not be used in patients with a known history of hypersensitivity to gentamicin, other aminoglycosides or materials of bovine origin.

It should not be used in patients who have previously had cancer in the bones, cartilage, fat or muscle of the treated limb.

Pre-existing conditions, including meniscal tears, joint instability, or malalignment should be assessed and treated prior to or concurrent with CARTICEL implantation.

CARTICEL is not routinely tested for transmissible infectious diseases and may transmit disease to the healthcare provider handling CARTICEL.

Use of CARTICEL in children, patients over age 65, or in joints other than the knee has not yet been assessed.

The occurrence of subsequent surgical procedures (SSPs), primarily arthroscopy, following CARTICEL implantation is common. In the Study of the Treatment of Articular Repair (STAR), forty-nine percent (49%) of patients underwent an SSP on the treated knee, irrespective of their relationship to CARTICEL, during the 4-year follow up. The most common serious adverse events (≥5% of patients), derived from STAR, include arthrofibrosis/joint adhesions, graft overgrowth, chondromalacia or chondrosis, cartilage injury, graft complication, meniscal lesion, graft delamination, and osteoarthritis.

For more information on CARTICEL, please see the Package Insert (PDF).